Matrix Metalloproteinases in Breast Cancer
- 1 May 1996
- journal article
- Published by Hindawi Limited in The Breast Journal
- Vol. 2 (3) , 209-220
- https://doi.org/10.1111/j.1524-4741.1996.tb00097.x
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The Epithelial to Mesenchymal Transition and Metastatic Progression in CarcinomaThe Breast Journal, 1996
- Cell surface binding of TIMP‐2 and pro‐MMP‐2/TIMP‐2 complexFEBS Letters, 1995
- Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopyVirchows Archiv, 1994
- Human progelatinase A can be activated by matrilysinFEBS Letters, 1994
- Oncogene-induced basement membrane invasiveness in human mammary epithelial cellsClinical & Experimental Metastasis, 1994
- Transforming growth factor-β1, β2, and β3, urokinase and parathyroid hormone-related peptide expression in 8701-BC breast cancer cells and clonesDifferentiation, 1993
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activityFEBS Letters, 1992
- Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990